These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17073704)

  • 1. Recent insights into the role of prostanoids in atherosclerotic vascular disease.
    Reiss AB; Edelman SD
    Curr Vasc Pharmacol; 2006 Oct; 4(4):395-408. PubMed ID: 17073704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
    Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
    Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases.
    Alfranca A; Iñiguez MA; Fresno M; Redondo JM
    Cardiovasc Res; 2006 Jun; 70(3):446-56. PubMed ID: 16458868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostanoid and isoprostanoid pathways in atherogenesis.
    Praticò D
    Atherosclerosis; 2008 Nov; 201(1):8-16. PubMed ID: 18514200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid function and cardiovascular disease.
    Iñiguez MA; Cacheiro-Llaguno C; Cuesta N; Díaz-Muñoz MD; Fresno M
    Arch Physiol Biochem; 2008 Jul; 114(3):201-9. PubMed ID: 18629685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
    Capra V; Bäck M; Barbieri SS; Camera M; Tremoli E; Rovati GE
    Med Res Rev; 2013 Mar; 33(2):364-438. PubMed ID: 22434418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostanoids in the pathophysiology of human coronary artery.
    Ozen G; Norel X
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():20-28. PubMed ID: 28347710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoids and prostanoid receptors in signal transduction.
    Bos CL; Richel DJ; Ritsema T; Peppelenbosch MP; Versteeg HH
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1187-205. PubMed ID: 15109566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular biology of eicosanoids and atherogenesis.
    Praticò D; Dogné JM
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1079-89. PubMed ID: 19764861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
    Gimbrone MA; García-Cardeña G
    Circ Res; 2016 Feb; 118(4):620-36. PubMed ID: 26892962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelium dysfunction: a conservative target in metabolic disorders.
    Jamwal S; Sharma S
    Inflamm Res; 2018 May; 67(5):391-405. PubMed ID: 29372262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium and inflammation.
    Piro M; Giubilato G; Pinnelli M; Giordano Sciacca P; Biasucci LM
    Panminerva Med; 2005 Jun; 47(2):75-80. PubMed ID: 16210992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.
    Xu S; Ilyas I; Little PJ; Li H; Kamato D; Zheng X; Luo S; Li Z; Liu P; Han J; Harding IC; Ebong EE; Cameron SJ; Stewart AG; Weng J
    Pharmacol Rev; 2021 Jul; 73(3):924-967. PubMed ID: 34088867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic cardiovascular disease: a review of initiators and protective factors.
    Ellulu MS; Patimah I; Khaza'ai H; Rahmat A; Abed Y; Ali F
    Inflammopharmacology; 2016 Feb; 24(1):1-10. PubMed ID: 26750181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelium - Gatekeeper of vessel health.
    Cahill PA; Redmond EM
    Atherosclerosis; 2016 May; 248():97-109. PubMed ID: 26994427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ; Juonala M; Raitakari OT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.